Latest Breaking News On - Catherine royer - Page 3 : comparemela.com

Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19 Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures, according to new study. Illustration credit: Jenna Luecke/University of Texas at Austin. AUSTIN, Texas Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in Cell Reports, researchers from The University of Texas at Austin, Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai showed that four drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures.

United statesBalasubramanian harishKris whiteThomas kehrerThomasb actonGaetano montelioneAdolfo garcHelena morenoTheresaa ramelotCatherine royerKhushboo bafnaRobertm krugRomel rosalesUniversity of texas at austinIcahn school of medicine at mount sinaiDefense advanced research projects agency